Published in Curr Opin Biotechnol on October 01, 1999
Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol (2003) 2.67
The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol. J Virol (2000) 1.95
New insights on adenovirus as vaccine vectors. Mol Ther (2009) 1.90
Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells. Mol Ther (2007) 1.76
"Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J Virol (2001) 1.53
Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization. J Virol (2001) 1.41
Molecular engineering of viral gene delivery vehicles. Annu Rev Biomed Eng (2008) 1.28
Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism. Circ Res (2003) 1.23
Hybrid nanoparticles for detection and treatment of cancer. Adv Mater (2012) 1.16
Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector. Mol Ther (2009) 1.10
Pseudopackaging of adenovirus type 5 genomes into capsids containing the hexon proteins of adenovirus serotypes B, D, or E. J Virol (2001) 1.09
Gene therapy for type I glycogen storage diseases. Curr Gene Ther (2007) 1.07
Adenovirus type 5 exerts genome-wide control over cellular programs governing proliferation, quiescence, and survival. Genome Biol (2007) 1.07
Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells. Cancer Biol Ther (2009) 1.05
Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells. J Virol (2004) 0.98
A rapid protocol for construction and production of high-capacity adenoviral vectors. Nat Protoc (2009) 0.97
Adenovirus-mediated gene transfer in mesenchymal stem cells can be significantly enhanced by the cationic polymer polybrene. PLoS One (2014) 0.95
Delivery of human immunodeficiency virus vaccine vectors to the intestine induces enhanced mucosal cellular immunity. J Virol (2009) 0.93
A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector. J Virol (2003) 0.92
Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer. J Virol (2001) 0.89
Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice. Gene Ther (2006) 0.89
Titration of non-replicating adenovirus as a vector for transducing active TGF-beta1 gene expression causing inflammation and fibrogenesis in the lungs of C57BL/6 mice. Int J Exp Pathol (2002) 0.89
Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth. Cancer Res (2012) 0.89
Therapeutic Vaccine Strategies against Human Papillomavirus. Vaccines (Basel) (2014) 0.89
Induction of a Protective Heterosubtypic Immune Response Against the Influenza Virus by using Recombinant Adenoviral Vectors Expressing Hemagglutinin of the Influenza H5 Virus. Acta Naturae (2010) 0.88
Gene therapy: light is finally in the tunnel. Protein Cell (2012) 0.87
Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives. Viruses (2010) 0.87
Helper-dependent adenoviral vectors in experimental gene therapy. Acta Biochim Pol (2005) 0.86
Study of hepatitis C virus entry in genetically humanized mice. Methods (2012) 0.85
Recombinant AAV-directed gene therapy for type I glycogen storage diseases. Expert Opin Biol Ther (2011) 0.85
Development and improvement of a serum-free suspension process for the production of recombinant adenoviral vectors using HEK293 cells. Cytotechnology (2001) 0.83
Vector and helper genome rearrangements occur during production of helper-dependent adenoviral vectors. Hum Gene Ther Methods (2013) 0.82
Adeno-associated virus (AAV) Rep protein enhances the generation of a recombinant mini-adenovirus (Ad) utilizing an Ad/AAV hybrid virus. J Virol (2000) 0.82
Gene therapy, early promises, subsequent problems, and recent breakthroughs. Adv Pharm Bull (2013) 0.82
Cell culture processes for the production of viral vectors for gene therapy purposes. Cytotechnology (2006) 0.82
Viral hybrid vectors for somatic integration - are they the better solution? Viruses (2009) 0.81
In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer. Exp Mol Med (2012) 0.81
The transduction of Coxsackie and Adenovirus Receptor-negative cells and protection against neutralizing antibodies by HPMA-co-oligolysine copolymer-coated adenovirus. Biomaterials (2011) 0.81
Development of viral vectors for gene therapy for chronic pain. Pain Res Treat (2011) 0.81
In vivo stable transduction of humanized liver tissue in chimeric mice via high-capacity adenovirus-lentivirus hybrid vector. Hum Gene Ther (2010) 0.80
Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses. Nucleic Acids Res (2015) 0.80
Improved transduction of human corneal epithelial progenitor cells with cell-targeting adenoviral vectors. Exp Eye Res (2006) 0.79
Construction of avian adenovirus CELO recombinants in cosmids. J Virol (2001) 0.79
Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies. Int J Mol Sci (2015) 0.79
Including the p53 ELAV-like protein-binding site in vector cassettes enhances transgene expression in rat submandibular gland. Oral Dis (2012) 0.78
Effective modifications for improved homologous recombination and high-efficiency generation of recombinant adenovirus-based vectors. J Virol Methods (2008) 0.78
A novel and simple method for construction of recombinant adenoviruses. Nucleic Acids Res (2006) 0.78
The promise and potential hazards of adenovirus gene therapy. Gut (2001) 0.78
Adoptive immunotherapy of cancer: Gene transfer of T cell specificity. Self Nonself (2011) 0.78
Gene therapy for Fabry disease. J Inherit Metab Dis (2001) 0.78
Replicating Single-cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses. J Virol (2016) 0.78
All human EF1α promoters are not equal: markedly affect gene expression in constructs from different sources. Int J Med Sci (2014) 0.76
Construction of a pIX-modified Adenovirus Vector Able to Effectively Bind to Nanoantibodies for Targeting. Acta Naturae (2014) 0.76
Adenovirus vector-mediated assay system for hepatitis C virus replication. Nucleic Acids Res (2011) 0.76
AT2R Gene Delivered by Condensed Polylysine Complexes Attenuates Lewis Lung Carcinoma after Intravenous Injection or Intratracheal Spray. Mol Cancer Ther (2015) 0.76
A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries. BMC Genomics (2008) 0.76
Inhibition of Pseudomonas aeruginosa with a recombinant RNA-based viral vector expressing human β-defensin 4. BMC Microbiol (2014) 0.75
Adenovirus vector-based incorporation of a photo-cross-linkable amino acid into proteins in human primary cells and cancerous cell lines. Sci Rep (2016) 0.75
A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products. Hum Gene Ther Methods (2016) 0.75
Production of recombinant adenovirus containing human interlukin-4 gene. Iran J Basic Med Sci (2011) 0.75
The targeted transduction of MMP-overexpressing tumor cells by ACPP-HPMA copolymer-coated adenovirus conjugates. PLoS One (2014) 0.75
Recombinant adenovirus-mediated overexpression of 3β-hydroxysteroid-Δ24 reductase. Neural Regen Res (2014) 0.75
Optimizing vector application for gene transfer into human hepatoblastoma cells. Pediatr Surg Int (2006) 0.75
Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses. Nature (1979) 6.60
Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science (1991) 6.28
The gene for polypeptide IX of adenovirus type 2 and its unspliced messenger RNA. Cell (1980) 5.80
Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med (1999) 4.92
Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest (1992) 4.43
A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. EMBO J (1988) 3.69
Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells. J Virol (1987) 3.56
Spliced RNA from the IR1-U2 region of Epstein-Barr virus: presence of an open reading frame for a repetitive polypeptide. EMBO J (1984) 3.12
A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus. J Virol (1987) 3.10
Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum Gene Ther (1990) 3.04
Epstein-Barr virus mRNAs produced by alternative splicing. Nucleic Acids Res (1986) 2.94
Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci U S A (1980) 2.88
An Epstein-Barr virus transcription unit is at least 84 kilobases long. Nucleic Acids Res (1986) 2.83
An adenovirus vector for gene transfer into neurons and glia in the brain. Science (1993) 2.79
Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature (1993) 2.73
Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nat Genet (1993) 2.67
Individual products of the adenovirus 12S and 13S EIa mRNAs stimulate viral EIIa and EIII expression at the transcriptional level. Proc Natl Acad Sci U S A (1984) 2.64
Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet (1992) 2.63
Structure of two adenovirus type 12 transforming polypeptides and their evolutionary implications. Nature (1980) 2.38
In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenoviruses. EMBO J (1985) 2.18
Recombinational construction in Escherichia coli of infectious adenoviral genomes. Proc Natl Acad Sci U S A (1997) 2.10
The E4 transcriptional unit of Ad2: far upstream sequences are required for its transactivation by E1A. Nucleic Acids Res (1984) 2.02
Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet (1993) 1.95
mRNAs from human adenovirus 2 early region 4. J Virol (1984) 1.92
A recombinant E1-deleted canine adenoviral vector capable of transduction and expression of a transgene in human-derived cells and in vivo. Hum Gene Ther (1997) 1.82
Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA. J Virol (1996) 1.71
Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. Proc Natl Acad Sci U S A (1992) 1.62
Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector. J Virol (1987) 1.61
Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J Virol (1996) 1.50
The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology (1994) 1.43
Adenoviral SERCA1a gene transfer to adult rat ventricular myocytes induces physiological changes in calcium handling. Cardiovasc Res (2001) 1.43
Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res (2000) 1.43
Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res (1996) 1.38
Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc Natl Acad Sci U S A (1998) 1.37
RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection. J Virol (1999) 1.37
BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res (2000) 1.36
Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J Clin Invest (1993) 1.35
Purification, cloning, and primary structure of a new enantiomer-selective amidase from a Rhodococcus strain: structural evidence for a conserved genetic coupling with nitrile hydratase. J Bacteriol (1991) 1.34
The sequence of the 3' non-coding region of the hexon mRNA discloses a novel adenovirus gene. Nucleic Acids Res (1981) 1.31
Construction of restriction enzyme fragment libraries containing DNA from human adenovirus types 2 and 5. Gene (1980) 1.29
Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat Genet (1993) 1.27
Predicted structure of two adenovirus tumor antigens. Proc Natl Acad Sci U S A (1980) 1.27
Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses. J Virol (1997) 1.23
Polyadenylic acid addition sites in the adenovirus type 2 major late transcription unit. J Virol (1983) 1.22
Receptors bound to antiprogestin from abortive complexes with hormone responsive elements. Nature (1988) 1.21
Expression mechanism of the hepatitis B virus (HBV) C gene and biosynthesis of HBe antigen. Virology (1989) 1.21
Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level. Biochem Biophys Res Commun (1991) 1.20
Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. Cancer Res (2001) 1.18
Stable multicopy vectors for high-level secretion of recombinant human serum albumin by Kluyveromyces yeasts. Biotechnology (N Y) (1991) 1.18
The E4 promoter of adenovirus type 2 contains an E1A dependent cis-acting element. Nucleic Acids Res (1986) 1.18
Advances in adenoviral vectors: from genetic engineering to their biology. FASEB J (1997) 1.18
Effects of intracameral injection of chondroitinase ABC in vivo. Arch Ophthalmol (1992) 1.17
Adenovirus and adeno-associated virus mediated gene transfer. Br Med Bull (1995) 1.17
Genetic and morphological evolution following a founder event in the dark-eyed junco, Junco hyemalis thurberi. Mol Ecol (2004) 1.16
Sympathetic innervation of lymph nodes in mice. Brain Res Bull (1984) 1.15
In vivo adenovirus-mediated gene transfer into ocular tissues. Gene Ther (1994) 1.14
Structure of three spliced mRNAs from region E3 of adenovirus type 2. Gene (1983) 1.13
Defective bacteriophage lambda chromosome, potential vector for DNA fragments obtained after cleavage by Bacillus amyloliquefaciens endonuclease (BamI). FEBS Lett (1975) 1.11
Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int J Cancer (1991) 1.11
Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice. Gene Ther (1998) 1.10
Recombinant adenoviruses as vaccines. Biologicals (1995) 1.10
High-level secretion of correctly processed recombinant human interleukin-1 beta in Kluyveromyces lactis. Gene (1991) 1.10
Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene (1999) 1.07
Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model. Proc Natl Acad Sci U S A (2000) 1.06
Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients. J Natl Cancer Inst (1996) 1.06
Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochem Biophys Res Commun (1993) 1.06
Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. J Gen Virol (1990) 1.06
Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc Natl Acad Sci U S A (1996) 1.04
AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice. Hum Gene Ther (2001) 1.03
Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. J Clin Invest (1997) 1.02
Measurement of d sigma/dM and forward-backward charge asymmetry for high-mass Drell-Yan e(+)e(-) pairs from pp macro collisions at square root of s = 1.8 TeV. Phys Rev Lett (2001) 1.02
Adenoviral-mediated gene transfer to renal tubular cells in vivo. Kidney Int (1994) 1.02
The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT). Biomed Imaging Interv J (2007) 1.02
Adenoviral vectors as functional retrograde neuronal tracers. Brain Res (1994) 0.99
Propagation in E. coli of bacteriophage lambda with integrated fragments of adenovirus 2 DNA. Gene (1976) 0.99
Highly efficient adenovirus-mediated gene transfer to cardiac myocytes after single-pass coronary delivery. Hum Gene Ther (2000) 0.99
Novel downstream elements upregulate transcription initiated from an Epstein-Barr virus latent promoter. EMBO J (1991) 0.98
Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses. Nat Genet (1995) 0.98
The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector. Gene Ther (1995) 0.97
Gene therapy using adenovirus vectors. Curr Top Microbiol Immunol (1995) 0.97
Adenoviral vector as a gene delivery system into cultured rat neuronal and glial cells. Eur J Neurosci (1993) 0.96
Genetic manipulations of adenovirus type 5 fiber resulting in liver tropism attenuation. Gene Ther (2003) 0.96
Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. Neuroreport (1994) 0.95
Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration. Gene Ther (2006) 0.95
Measurement of the strong coupling constant from inclusive jet production at the Tevatron pp collider. Phys Rev Lett (2002) 0.94
Bacteriophage lambda and plasmid vectors, allowing fusion of cloned genes in each of the three translational phases. Nucleic Acids Res (1978) 0.94
cDNA cloning and transient expression of the Epstein-Barr virus-determined nuclear antigen EBNA3B in human cells and identification of novel transcripts from its coding region. J Virol (1990) 0.94
Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J Clin Invest (1995) 0.94
Expression of human alpha 1-antitrypsin using a recombinant adenovirus vector. FEBS Lett (1990) 0.94